Depression and Anxiety Trial, Recruiting (NCT07050498)

Depression and Anxiety Trial, Recruiting NCT07050498 Sponsor: GCS Ramsay Santé pour l'Enseignement et la Recherche Condition: Depression and Anxiety

Printed from Voxsanity (voxsanity.com.au) — NCT07050498 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Depression And Anxiety

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Adults aged 18 years or older
People who have read and signed a consent form after a set reflection period (between 10 and 45 minutes)
People who have been assessed as suitable candidates for refractive (vision-correcting) eye surgery

Who may not be able to join:

People for whom virtual reality use is not medically appropriate, including those with uncontrolled epilepsy or a hearing impairment
People who are currently pregnant or breastfeeding
People with certain hormonal or adrenal conditions, including Cushing's disease, Addison's disease, or an underactive or overactive thyroid
People currently being treated with corticosteroid medications, whether applied to the skin or taken as a whole-body (systemic) treatment
People currently taking antipsychotic medications (neuroleptics), anti-anxiety medications (anxiolytics), or antidepressants
People who are under a legal protection order, guardianship, or curatorship
People who are already taking part in another blinded research study
People who are not affiliated with the French social security system
People who are unable to understand the information provided or give written consent — for example, due to dementia, psychosis, reduced consciousness, or not speaking French

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 23 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07050498

Sponsor: GCS Ramsay Santé pour l'Enseignement et la Recherche

Phase: Not Applicable

Status: Recruiting

Condition: Depression and Anxiety

More information: https://clinicaltrials.gov/study/NCT07050498

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Adults aged 18 years or older
People who have read and signed a consent form after a set reflection period (between 10 and 45 minutes)
People who have been assessed as suitable candidates for refractive (vision-correcting) eye surgery

Who may not be able to join:

People for whom virtual reality use is not medically appropriate, including those with uncontrolled epilepsy or a hearing impairment
People who are currently pregnant or breastfeeding
People with certain hormonal or adrenal conditions, including Cushing's disease, Addison's disease, or an underactive or overactive thyroid
People currently being treated with corticosteroid medications, whether applied to the skin or taken as a whole-body (systemic) treatment
People currently taking antipsychotic medications (neuroleptics), anti-anxiety medications (anxiolytics), or antidepressants
People who are under a legal protection order, guardianship, or curatorship
People who are already taking part in another blinded research study
People who are not affiliated with the French social security system
People who are unable to understand the information provided or give written consent — for example, due to dementia, psychosis, reduced consciousness, or not speaking French

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 23 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

GCS Ramsay Santé pour l'Enseignement et la Recherche

Registry

ClinicalTrials.gov

Start date

18 September 2024

Est. completion

18 September 2026

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Preoperative anxiety level

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov